You are here

  • Home
  • Archive
  • Volume 67, Issue 2
  • Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction

Article info

Article menu

Download PDFPDF

XML
Gut microbiota
Original article
Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction

Authors

  • Emilie Catry Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Laure B Bindels Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Anne Tailleux European Genomic Institute for Diabetes (EGID), Univ Lille, Lille, France INSERM UMR 1011, Lille, France Institut Pasteur de Lille, Lille, France CHU de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Sophie Lestavel European Genomic Institute for Diabetes (EGID), Univ Lille, Lille, France INSERM UMR 1011, Lille, France Institut Pasteur de Lille, Lille, France CHU de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Audrey M Neyrinck Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Jean-François Goossens Centre Universitaire de Mesures et d'Analyses, Univ. Lille, Lille, France EA 7365 GRITA, Lille, France PubMed articlesGoogle scholar articles
  • Irina Lobysheva Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Hubert Plovier Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium Walloon Excellence in Life sciences and BIOtechnology (WELBIO), Belgium PubMed articlesGoogle scholar articles
  • Ahmed Essaghir Pole of Experimental Medicine, de Duve Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Jean-Baptiste Demoulin Pole of Experimental Medicine, de Duve Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Caroline Bouzin IREC Imaging Platform, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Barbara D Pachikian Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Patrice D Cani Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium Walloon Excellence in Life sciences and BIOtechnology (WELBIO), Belgium PubMed articlesGoogle scholar articles
  • Bart Staels European Genomic Institute for Diabetes (EGID), Univ Lille, Lille, France INSERM UMR 1011, Lille, France Institut Pasteur de Lille, Lille, France CHU de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Chantal Dessy Pole of Pharmacology and Therapeutics, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  • Nathalie M Delzenne Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Nathalie M Delzenne, Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, 73, avenue E. Mounier, B01.73.11, Brussels 1200, Belgium; nathalie.delzenne{at}uclouvain.be
View Full Text

Citation

Catry E, Bindels LB, Tailleux A, et al
Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction
Gut 2018;67:271-283.

Publication history

  • Received October 27, 2016
  • Revised February 17, 2017
  • Accepted February 20, 2017
  • First published April 4, 2017.
Online issue publication 
April 20, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/